食物アレルギー治療の市場規模、シェア、動向分析レポート：アレルゲンタイプ別、薬剤タイプ別、投与経路別、最終用途別、地域別、セグメント予測、2025年～2030年

食物アレルギー治療市場の成長と動向

Grand View Research, Inc.の最新レポートによると、食物アレルギー治療の世界市場規模は2030年までに113億3,000万米ドルに達すると予測され、2025～2030年のCAGRは8.27％で成長すると予測されています。

市場成長を促進する主要要因には、世界の食物アレルギーの有病率の上昇、新規薬剤の研究開発活動の活発化などがあります。さらに、食物アレルギーを治療するための新たな生物学的薬剤の採用や、食物アレルギーの治療を求める患者によるクリニック受診の増加が、予測期間中の市場成長を促進する可能性が高いです。

アレルギー治療に対する資金援助の増加は、革新的な治療法の研究開発と入手の容易性の向上を促進し、より効果的な治療法と管理戦略に対する需要の高まりに対応しています。このような財政支援の強化は、市場の成長を促進し、この症状に罹患している人々にとってより安全で利用しやすいソリューションの開拓に拍車をかけています。2022年9月、臨床段階のバイオテクノロジー企業であるCOUR Pharmaceuticalsは、Alpha Wave Venturesを主要投資家とする3,000万米ドルの資金調達ラウンドを完了しました。この資金調達は、COURの革新的な免疫修飾ナノ粒子（COUR NanoParticlesまたはCNPs）技術プラットフォームの拡大を支援します。さらに、食物アレルギーの治療に焦点を当てた2つのヒトでの概念実証検査の進行も促進されます。この重要な投資は、自己免疫疾患と食物アレルギーに対処するための免疫系再プログラミング・アプローチを前進させる可能性を強調するものです。

XolairやPALFORZIAなどの新薬が市場の成長を後押しします。2020年1月、FDAによるPALFORZIAの承認は食物アレルギー治療における重要なマイルストーンとなりました。PALFORZIAは、ピーナッツアレルギーの治療選択肢を提供することで、極めて重要なアンメット・メディカル・ニーズに応えるものです。承認以前は、患者は厳格な回避以外に限られた選択肢しかありませんでしたが、今回の承認により、人生を変える可能性のある解決策が導入されました。この経口免疫療法製品は、ピーナッツアレルギーと確定診断された4歳から17歳の小児において、偶発的なピーナッツ暴露により起こりうるアナフィラキシーを含むアレルギー反応を軽減することを特に適応としています。FDAのリスク評価・軽減戦略（REMS）要件により、PALFORZIAの安全かつ管理された投与が保証され、患者の安全性と医療従事者の信頼が高まります。PALFORZIAは、ピーナッツを避ける食事療法と並行して使用され、患者のニーズに合わせて調整される一方、コントロールされていない喘息や好酸球性食道炎とその他の好酸球性消化器疾患の場合には禁忌とされており、その安全性と特定の患者集団への適合性がさらに強調されています。

しかし、Nestleのパルフォルジアは大きな課題に直面しました。開発には26億米ドルが投じられたにもかかわらず、その治療法は多くの潜在的患者にとって面倒であることが判明したのです。2020年にパルフォルツィアが市場に投入されると、医師たちは当初、この薬を患者に提供することに胸を躍らせた。しかし、COVID-19の大流行により、対面での治療計画は中断されました。その結果、医師たちは約1,000人の患者に対して、パンデミック後の選択肢としてこの新薬について伝えることにしました。生命を脅かすピーナッツアレルギーの効率的な解決法として注目され、米国当局の認可を得たこの治療に興味を示したのは、意外にもわずか6人だけでした。年経っても、多くの医師はパルフォルジアを配合していないです。米国全土で、医師と患者はアレルゲンを避け、緊急時のためにアドレナリン注射を携帯するという従来の方法を選んでいるようです。市場開拓の重要な進展として、2023年9月、Nestleはパルフォルジア事業をアレルギー診断・治療を専門とするStallergenes Greerに売却しました。この戦略的な動きは、Nestleが先に発表したPalforziaの見直しに続くもので、Nestleは契約の一環としてマイルストーン決済と継続的なロイヤルティを受け取ることになっています。

食物アレルギー治療市場レポートハイライト

• アレルゲンタイプ別では、ピーナッツセグメントが2024年に20.55%の最大売上シェアで市場をリードしています。市場成長を促進する主要要因としては、世界のピーナッツアレルギーの有病率の上昇、新薬の研究開発活動の活発化などが挙げられます。さらに、アレルギーを治療するための新しい生物学的薬剤の採用が増加していることや、このアレルギーの治療を求める患者の来院が増加していることも、予測期間中の市場成長を促進するとみられます。
• 薬剤タイプ別では、エピネフリン部門が2024年に41.0%の最大売上シェアで市場をリードしました。エピネフリンは、アレルギー症状の治療に選択される薬剤と考えられています。緊急のアレルギー症状の初期治療として使用されるためです。
• 投与経路別では、経口投与が予測期間中に安定したCAGRで成長すると予測されています。経口投与食物アレルギー治療は主に経口免疫療法（OIT）を採用しており、制御された量の食物アレルゲンを徐々に摂取します。
• 最終用途別では、病院薬局部門が2024年に55.48％の最大収益シェアで市場を占めました。病院薬局は重要な流通チャネルとして機能し、病院環境内で食物アレルギーを管理するために不可欠な医薬品や治療法の入手と効率的な調剤を促進します。
• 北米は2024年に39.14%の収益シェアで市場を独占しました。同地域は、アレルギー治療に関連する高い可能性に対する理解の高まりにより、主要な市場シェアを占めています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 食物アレルギー治療市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 食物アレルギー治療市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • 価格分析

第4章 食物アレルギー治療市場：アレルゲンタイプ別、推定・動向分析

• セグメントダッシュボード
• 世界の食物アレルギー治療市場のアレルゲンタイプの変動分析
• 世界の食物アレルギー治療市場の規模と動向分析、アレルゲンタイプ別、2018～2030年
• 乳製品
• 家禽製品
• 木の実
• ピーナッツ
• 貝
• 小麦
• 大豆
• その他

第5章 食物アレルギー治療市場： 薬剤タイプ別、推定・動向分析

• セグメントダッシュボード
• 世界の食物アレルギー治療市場の薬剤タイプの変動分析
• 世界の食物アレルギー治療市場の規模と動向分析、薬剤タイプ別、2018～2030年
• 抗ヒスタミン薬
• エピネフリン
• 免疫療法
  • ゾレア
  • パルフォルジア
  • その他

第6章 食物アレルギー治療市場：投与経路別、推定・動向分析

• セグメントダッシュボード
• 世界の食物アレルギー治療市場の変動分析
• 世界の食物アレルギー治療市場の規模と動向分析、投与経路別、2018～2030年
• 非経口投与
• 経口投与
• その他

第7章 食物アレルギー治療市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 世界の食物アレルギー治療市場の変動分析
• 世界の食物アレルギー治療市場の規模と動向分析、最終用途別、2018～2030年
• 病院薬局
• 小売薬局
• その他

第8章 食物アレルギー治療市場：地域別、推定・動向分析

• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店とチャネルパートナー一覧
  • 主要企業の市場シェア分析、2024年
  • Sanofi SA
  • Stallergenes Greer
  • DBV Technologies
  • Vedanta Biosciences, Inc.
  • Alladapt Immunotherapeutics, Inc.
  • COUR Pharmaceuticals
  • Aravax
  • Prota Therapeutics Pty Ltd
  • Teva Pharmaceuticals Industries Ltd.
  • F. Hoffman-La Roche Ltd.
  • Novartis AG

第10章 結論

List of Tables

• Table 1 List of key distributors and channel partners
• Table 2 List of key emerging companies'/technology disruptors/innovators
• Table 3 North America Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
• Table 4 North America Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 5 North America Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 6 North America Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 7 North America Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 8 U.S. Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 9 U.S. Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 10 U.S. Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 11 U.S. Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 12 Canada Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 13 Canada Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 14 Canada Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 15 Canada Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 16 Mexico Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 17 Mexico Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 18 Mexico Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 19 Mexico Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 20 Europe Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
• Table 21 Europe Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 22 Europe Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 23 Europe Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 24 Europe Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 25 Germany Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 26 Germany Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 27 Germany Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 28 Germany Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 29 UK Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 30 UK Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 31 UK Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 32 UK Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 33 France Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 34 France Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 35 France Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 36 France Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 37 Italy Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 38 Italy Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 39 Italy Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million
• Table 40 Italy Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 41 Spain Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 42 Spain Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 43 Spain Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 44 Sapin Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 45 Denmark Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 46 Denmark Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 47 Denmark Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 48 Denmark Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 49 Sweden Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 50 Sweden Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 51 Sweden Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 52 Sweden Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 53 Norway Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 54 Norway Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 55 Norway Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 56 Norway Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 62 Japan Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 63 Japan Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 64 Japan Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 65 Japan Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 66 China Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 67 China Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 68 China Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 69 China Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 70 India Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 71 India Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 72 India Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 73 India Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 74 Australia Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 75 Australia Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 76 Australia Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 77 Australia Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 78 South Korea Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 79 South Korea Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 80 South Korea Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 81 South Korea Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 82 Thailand Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 83 Thailand Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 84 Thailand Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 85 Thailand Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 86 Latin America Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
• Table 87 Latin America Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 88 Latin America Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 89 Latin America Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million
• Table 90 Latin America Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 91 Brazil Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 92 Brazil Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 93 Brazil Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 94 Brazil Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 95 Argentina Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 96 Argentina Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 97 Argentina Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 98 Argentina Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 99 MEA Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
• Table 100 MEA Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 101 MEA Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 102 MEA Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 103 MEA Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 104 South Africa Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 105 South Africa Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 106 South Africa Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 107 South Africa Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 111 Saudi Arabia Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 112 UAE Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 113 UAE Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 114 UAE Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 115 UAE Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Table 116 Kuwait Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
• Table 117 Kuwait Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Table 118 Kuwait Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 119 Kuwait Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Food Allergy Treatment Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Food Allergy Treatment Market snapshot (2023)
• Fig. 9 Food Allergy Treatment Market: Segment snapshot (2023)
• Fig. 10 Competitive Insights (2023)
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Food Allergy Treatment Market driver impact
• Fig. 15 Food Allergy Treatment Market restraint impact
• Fig. 16 Porter's Five Forces Analysis
• Fig. 17 SWOT Analysis, By Factor (Political & legal Economic and technological)
• Fig. 18 Strategic alliance analysis
• Fig. 19 Recent developments & impact analysis, by key market participants
• Fig. 20 Key company market share analysis, 2024
• Fig. 21 Company market position analysis
• Fig. 22 Definition and scope, by Allergen Type
• Fig. 23 Allergen Type market share analysis, 2024 & 2030
• Fig. 24 Global Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
• Fig. 25 Dairy Products market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 26 Poultry Product market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 27 Tree Nuts market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 28 Peanuts market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 29 Shellfish market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 30 Wheat market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 31 Soys market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 32 Other market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 33 Definition and scope, by drug type
• Fig. 34 Drug type market share analysis, 2024 & 2030
• Fig. 35 Global Food Allergy Treatment Market, by drug type, 2018 - 2030 (USD Million)
• Fig. 36 Antihistamines market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 37 Epinephrine market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 38 Immunotherapy market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 39 Xolair market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 40 PALFORZIA NSAIDs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 41 Other immunotherapies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 42 Definition and scope, by Route of Administration
• Fig. 43 Route of Administration market share analysis, 2024 & 2030
• Fig. 44 Global Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
• Fig. 45 Parenteral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 46 Oral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 47 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 48 Definition and scope, by End Use
• Fig. 49 End Use market share analysis, 2024 & 2030
• Fig. 50 Segment dashboard
• Fig. 51 Global Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
• Fig. 52 Hospital Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 53 Retail Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 54 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 55 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 56 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 57 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 58 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 59 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 60 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 61 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 62 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 63 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 64 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 65 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 66 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 67 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 68 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 69 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 70 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 71 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 72 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 73 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 74 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 75 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 76 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 77 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
• Fig. 78 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 79 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 80 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 81 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 82 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)

Food Allergy Treatment Market Growth & Trends:

The global food allergy treatment market size is anticipated to reach USD 11.33 billion by 2030 and is projected to grow at a CAGR of 8.27% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key factors propelling the market growth includes the rising prevalence of food allergies worldwide and increasing R&D activities for novel drugs. Moreover, the adoption of new biological agents to treat food allergies and an increase in clinic visits by patients seeking therapy for food allergies are likely to drive the market growth over the forecast period.

The increase in funding for allergy treatments is driving advancements in research, development, and accessibility of innovative therapies, addressing the growing demand for more effective treatments & management strategies. This heightened financial support is propelling market growth and fueling the development of safer and more accessible solutions for those affected by this condition. In September 2022, COUR Pharmaceuticals, a clinical-stage biotechnology company, completed a USD 30 million financing round, with Alpha Wave Ventures as the lead investor. This funding will support the expansion of COUR's innovative immune-modifying nanoparticles (COUR NanoParticles or CNPs) technology platform. Furthermore, it will facilitate the progression of the company's two human proof-of-concept studies focused on treating food allergies. This significant investment highlights the potential for advancing immune system reprogramming approaches to address autoimmune disorders and food allergies.

Novel drugs such as Xolair, and PALFORZIA boost the market growth. In January 2020, the FDA's approval of PALFORZIA marked a significant milestone in Food Allergy Treatment. PALFORZIA addresses a crucial unmet medical need by providing a treatment option for peanut allergies. Prior to its approval, patients had limited choices beyond strict avoidance, and this approval introduced a potentially life-changing solution. This oral immunotherapy product is specifically indicated for mitigating allergic reactions, including anaphylaxis that might occur from accidental peanut exposure in children aged 4 to 17 years with a confirmed diagnosis of peanut allergy. The FDA's requirement for a Risk Evaluation and Mitigation Strategy (REMS) ensures the safe and controlled administration of PALFORZIA, boosting patient safety and healthcare provider confidence. PALFORZIA, used alongside a peanut-avoidant diet, is tailored to meet the needs of patients while being contraindicated in cases of uncontrolled asthma and eosinophilic esophagitis and other eosinophilic gastrointestinal diseases, further emphasizing its safety and suitability for specific patient populations.

However, Nestle's Palforzia faced significant challenges. Despite a substantial investment of USD 2.6 billion in its development, the treatment regimen proved to be too cumbersome for many potential patients. When Palforzia entered the market in 2020, physicians were initially excited to offer it to their patients. However, the COVID-19 pandemic disrupted in-person treatment plans. As a result, doctors resorted to informing approximately 1,000 patients about the new drug as an option for postpandemic use. Surprisingly, only six individuals expressed interest in the treatment that had been heralded as an efficient solution for life-threatening peanut allergy, having received clearance from U.S. authorities. Even after three years, many physicians have not prescribed Palforzia. Across the U.S., it appears that doctors & patients are opting for the traditional approach of avoiding allergens and carrying adrenaline injections for emergencies instead. As a significant development in the market, in September 2023, Nestle divested its Palforzia business to Stallergenes Greer, a company specifying in allergy diagnosis and treatment. This strategic move followed Nestle's earlier announcement of a review of Palforzia, with Nestle set to receive milestone payments and ongoing royalties as part of the agreement.

Food Allergy Treatment Market Report Highlights:

• By allergen type, the peanuts segment led the market with the largest revenue share of 20.55% in 2024. Key factors propelling market growth include, rising prevalence of peanut allergies worldwide and increasing R&D activities for novel drugs. Moreover, growing adoption of new biological agents to treat allergies and an increase in clinic visits by patients seeking therapy for this allergy are likely to drive the market growth over the forecast period
• Based on drug type, the epinephrine segment led the market with the largest revenue share of 41.0% in 2024. Epinephrine is considered to be the medication of choice for treatment of allergic conditions. Owing to its use as the initial treatment of choice for emergency allergic conditions
• By route of administration, the oral segment is projected to grow at a steady CAGR over the forecast period. Oral food allergy treatment primarily employs Oral Immunotherapy (OIT), involving the gradual consumption of controlled amounts of food allergen
• By end use, the hospital pharmacies segment held the market with the largest revenue share of 55.48% in 2024. Hospital pharmacies serve as a critical distribution channel, facilitating the availability and efficient dispensation of medications and treatments essential for managing food allergies within a hospital environment
• North America dominated the market with the revenue share of 39.14% in 2024. The region held a major market share due to an increase in understanding of the high potential associated with allergy drugs

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Drug Type
  • 1.2.2. Allergen Type
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Food Allergy Treatment Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of peanut allergy
    • 3.2.1.2. Increasing funding for novel drug discovery
    • 3.2.1.3. Rising awareness programs
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of treatment and products
• 3.3. Food Allergy Treatment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pricing Analysis

Chapter 4. Food Allergy Treatment Market: Allergen Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Food Allergy Treatment Market by Allergen Type Outlook
• 4.3. Global Food Allergy Treatment Market Size & Trend Analysis, by Allergen Type, 2018 to 2030 (USD Million)
• 4.4. Dairy Products
  • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Poultry Product
  • 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Tree Nuts
  • 4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.7. Peanuts
  • 4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.8. Shellfish
  • 4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.9. Wheat
  • 4.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.10. Wheat
  • 4.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.11. Soys
  • 4.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.12. Other
  • 4.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Food Allergy Treatment Market: Drug Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Food Allergy Treatment Market Drug Type Movement Analysis
• 5.3. Global Food Allergy Treatment Market Size & Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
• 5.4. Antihistamines
  • 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Epinephrine
  • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Immunotherapy
  • 5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6.2. Xolair
    • 5.6.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6.3. PALFORZIA
    • 5.6.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6.4. Others
    • 5.6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Food Allergy Treatment Market: Route of Administration Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Food Allergy Treatment Market Movement Analysis
• 6.3. Global Food Allergy Treatment Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
• 6.4. Parenteral Route
  • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Oral Route
  • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Other
  • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Food Allergy Treatment Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Food Allergy Treatment Market Movement Analysis
• 7.3. Global Food Allergy Treatment Market Size & Trend Analysis, by End Use 2018 to 2030 (USD Million)
• 7.4. Hospital Pharmacies
  • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Retail Pharmacies
  • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Food Allergy Treatment Market: Regional Estimates & Trend Analysis by

• 8.1. Regional Market Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2024
  • 9.3.4. Sanofi SA
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Stallergenes Greer
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. DBV Technologies
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Vedanta Biosciences, Inc.
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Alladapt Immunotherapeutics, Inc.
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. COUR Pharmaceuticals
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Aravax
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Prota Therapeutics Pty Ltd
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Teva Pharmaceuticals Industries Ltd.
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. F. Hoffman-La Roche Ltd.
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. Novartis AG
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Product benchmarking
    • 9.3.14.4. Strategic initiatives

Chapter 10. Conclusion